Article

Sugar-Sweetened Beverage, Sugar Intake of Individuals, and Their Blood Pressure International Study of Macro/Micronutrients and Blood Pressure

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom.
Hypertension (Impact Factor: 7.63). 02/2011; 57(4):695-701. DOI: 10.1161/HYPERTENSIONAHA.110.165456
Source: PubMed

ABSTRACT The obesity epidemic has focused attention on relationships of sugars and sugar-sweetened beverages (SSBs) to cardiovascular risk factors. Here we report cross-sectional associations of SSBs, diet beverages, and sugars with blood pressure (BP) for United Kingdom and US participants of the International Study of Macro/Micronutrients and Blood Pressure. Data collected include four 24-hour dietary recalls, two 24-hour urine collections, 8 BP readings, and questionnaire data for 2696 people ages 40 to 59 years of age from 10 US/United Kingdom population samples. Associations of SSBs, diet beverages, and sugars (fructose, glucose, and sucrose) with BP were assessed by multiple linear regression. SSB intake related directly to BP, with P values of 0.005 to <0.001 (systolic BP) and 0.14 to <0.001 (diastolic BP). SSB intake higher by 1 serving per day (355 mL/24 hours) was associated with systolic/diastolic BP differences of +1.6/+0.8 mm Hg (both P<0.001) and +1.1/+0.4 mm Hg (P<0.001/<0.05) with adjustment for weight and height. Diet beverage intake was inversely associated with BP (P 0.41 to 0.003). Fructose- and glucose-BP associations were direct, with significant sugar-sodium interactions: for individuals with above-median 24-hour urinary sodium excretion, fructose intake higher by 2 SD (5.6% kcal) was associated with systolic/diastolic BP differences of +3.4/+2.2 mm Hg (both P<0.001) and +2.5/+1.7 mm Hg (both P=0.002) with adjustment for weight and height. Observed independent, direct associations of SSB intake and BP are consistent with recent trial data. These findings, plus adverse nutrient intakes among SSB consumers, and greater sugar-BP differences for persons with higher sodium excretion lend support to recommendations that intake of SSBs, sugars, and salt be substantially reduced.

Download full-text

Full-text

Available from: Claire E Robertson, Jul 02, 2015
0 Followers
 · 
179 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: High consumption of fructose-sweetened beverages has been linked to a high prevalence of chronic metabolic diseases. We have previously shown that a short course of fructose supplementation as a liquid solution induces glucose intolerance in female rats. In the present work, we characterized the fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid fructose (10%, w/v) for 7 or 14 days. Glucose and pyruvate tolerance tests were performed, and the expression of genes related to insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated. Fructose-supplemented rats showed increased plasma glucose excursions in glucose and pyruvate tolerance tests and reduced hepatic expression of several genes related to insulin signaling, including insulin receptor substrate 2 (IRS-2). However, the expression of key gluconeogenic enzymes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, was reduced. These effects were caused by an inactivation of hepatic forkhead box O1 (FoxO1) due to an increase in its acetylation state driven by a reduced expression and activity of sirtuin 1 (SIRT1). Further contributing to FoxO1 inactivation, fructose consumption elevated liver expression of the spliced form of X-box-binding-protein-1 as a consequence of an increase in the activity of the mammalian target of rapamycin 1 and protein 38-mitogen activated protein kinase (p38-MAPK). Liquid fructose affects both insulin signaling (IRS-2 and FoxO1) and nutrient sensing pathways (p38-MAPK, mTOR and SIRT1), thus disrupting hepatic insulin signaling without increasing the expression of key gluconeogenic enzymes.
    The Journal of nutritional biochemistry 02/2014; 25(2):250-8. DOI:10.1016/j.jnutbio.2013.10.014 · 4.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease (CVD) is the leading cause of death worldwide. Risk of CVD is determined by genetic and environmental factors. Numerous dietary factors have been linked to CVD beyond the conventional risk factors. In the past few years, genome-wide association studies have also identified more than 30 genomic loci that determine the susceptibility to cardiovascular events. Genetic background may interact with habitual dietary compositions in predisposition to CVD. In this context, large-scale studies of gene–diet interaction in prospective cohorts or randomized intervention trials have emerged to integrate genetic and dietary risk factors in predicting cardiovascular risk. The use of genetic variants to estimate a causal effect between dietary factors and CVD, namely mendelian randomization analysis, has also been considered in the nutritional epidemiology field. The purpose of this review is to present recent advances in research into dietary and genetic risk factors, gene–diet interactions, and mendelian randomization with regard to CVD risk.
    06/2012; 1(2). DOI:10.1007/s13668-012-0008-0
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A large part of blood pressure variation among individuals cannot be explained by known nutritional and dietary factors, and thus, many studies are in progress. We reviewed recent observational and interventional studies investigating the relationship of dietary and nutritional factors to blood pressure in human populations. During the past few years, a cross-sectional study of large-scale international populations, the INTERMAP (International Study of Macro/Micronutrients and Blood Pressure), reported the favorable effects of several nutrients, including minerals (phosphorus, calcium, magnesium, and non-heme iron), glutamic acid, n-6 and n-3 polyunsaturated fatty acids, and starch, and reduced intake of cholesterol, glucose, and fructose. Observational and interventional studies also showed new evidence suggesting unfavorable effects resulting from higher intakes of red meat, fructose, and sugar-sweetened beverages, and favorable effects resulting from higher intake of lactotripeptides and polyphenol-rich dark chocolate. For the Dietary Approaches to Stop Hypertension (DASH) dietary pattern, further evidence on blood pressure–lowering effects and other favorable outcomes has accumulated. These new findings should be established by further studies for the future update of dietary guidelines to prevent and manage hypertension.
    06/2012; 1(2). DOI:10.1007/s13668-012-0012-4